To test this hypothesis, we examined the relationship between FLCN expression and gene set enrichment in a variety of other tumor tissue types, using a data set that includes tumors of the breast, cervix, colon, kidney, lung, lymph, ovary, pancreas, prostate, stomach, thyroid, and vulva, with matched normal tissue of each tissue type. The gene discussed is FLCN; the disease is neoplasm.